Arthur Hiller is a highly accomplished biotech, pharmaceutical, and life sciences executive with extensive experience in creating and growing companies, launching products, and building and expanding commercial operations. He holds an MS in Business Policy from Columbia University's Columbia Business School, and a BS in Journalism from Northwestern University.

Hiller's career includes stints as Chief Business Officer at Nuritas, interim CEO and business advisor to various life sciences companies, Chief Executive Officer of Amasa Therapeutics, senior roles at Millennium Pharmaceuticals and Merck & Co., and several other executive positions. He has also provided strategic consulting and business advisory services to start-ups, including Heartscape Technologies and Geppetto Avatars, Inc.

Hiller's areas of expertise include commercialization and growth strategy, business development, new technology identification and assessment, digital health and blockchain technology strategy, and strong written and oral communication skills. He has broad functional experience in product launch, branding, positioning, global sales and marketing, and market access. Throughout his career, Hiller has demonstrated a remarkable ability to drive revenue growth and create significant value for shareholders.